Invention Grant
- Patent Title: TLR7/8 antagonists and uses thereof
-
Application No.: US15670068Application Date: 2017-08-07
-
Publication No.: US10947214B2Publication Date: 2021-03-16
- Inventor: Brian A. Sherer , Xiaoling Chen , Esther Cleary , Nadia Brugger
- Applicant: Merck Patent GmbH
- Applicant Address: DE Darmstadt
- Assignee: Merck Patent GmbH
- Current Assignee: Merck Patent GmbH
- Current Assignee Address: DE Darmstadt
- Agency: Grüneberg and Myers PLLC
- Main IPC: C07D401/04
- IPC: C07D401/04 ; C07D401/14 ; C07D413/14 ; C07D215/18 ; C07D413/04 ; C07D401/12 ; A61K31/4709 ; C07D215/12 ; C07D215/14 ; C07D241/42 ; C07D451/02 ; C07D471/04 ; C07D471/08 ; C07D471/10 ; C07D487/04
Abstract:
The present invention relates to compounds of Formula I and pharmaceutically acceptable compositions thereof, useful as TLR7/8 antagonists.
Public/Granted literature
- US20180037570A1 TLR7/8 ANTAGONISTS AND USES THEREOF Public/Granted day:2018-02-08
Information query
